GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Alexandria
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and manages campuses for biotech and pharmaceutical companies. Its share price reflects the volume of venture capital funding in the life sciences industry and the demand for specialized laboratory space.
Share prices of companies in the market segment - Investors specialized
Alexandria Real Estate is a REIT operating in a highly niche segment: owning and managing campuses for biotech and pharmaceutical companies. We classify it as a specialized investor. The chart below illustrates the dynamics of this unique real estate sector.
Broad Market Index - GURU.Markets
Alexandria Real Estate Equities is a REIT that specializes in owning, managing, and developing campuses for life sciences companies. As a leader in its niche, it is included in the GURU.Markets index. The chart below shows the overall market performance. Compare its stock performance to trends in the biotech industry.
Change in the price of a company, segment, and market as a whole per day
ARE - Daily change in the company's share price Alexandria
For Alexandria, a life sciences REIT, the daily price change reflects its sensitivity to biotech funding. While the chart of these fluctuations isn't particularly visual, it's an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Investors specialized
Alexandria Real Estate Equities, Inc. is a REIT focused on life science real estate. This chart shows the sector's average daily volatility. Comparing it to ARE's performance helps understand how resilient its unique niche, dependent on biotech R&D budgets, is to overall trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Alexandria Real Estate is a unique real estate investment trust (REIT) specializing in the development and management of life sciences campuses. Its growth is closely tied to the health of the biotech industry. The chart below shows overall market volatility, allowing you to assess the dynamics of this niche leader.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Alexandria
Alexandria is a unique REIT specializing in real estate for biotech and pharmaceutical companies. Its year-over-year performance serves as a barometer of R&D investment in the life sciences sector. The chart below tells the story of this science-intensive business.
Annual dynamics of market capitalization of the market segment - Investors specialized
Alexandria Real Estate Equities, Inc. is a unique REIT focused on owning and developing campuses for biotech and pharmaceutical companies. Its success is closely tied to the growth of R&D spending in the life sciences industry. The chart below shows how its niche specialization allows it to outperform the real estate sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Alexandria Real Estate Equities (ARE) is a REIT specializing in the ownership and management of office and laboratory space for biotech companies. Its unique niche allows it to benefit from the growth of the life sciences industry, making it less dependent on general office cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Alexandria
The value of Alexandria Real Estate (ARE), a REIT focused on biotech real estate, is dependent on funding cycles in the industry. The monthly fluctuations on the chart reflect the demand for lab and office space, which is directly linked to the volume of venture capital investments and R&D budgets in the life sciences sector.
Monthly dynamics of market capitalization of the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a REIT pioneering and leading the development and management of office and laboratory campuses for biotech and pharmaceutical companies. Its sector dynamics, shown in the graph, reflect the demand for scientific space. This allows us to understand how ARE's cluster strategy in leading innovation hubs creates a unique ecosystem for science.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Alexandria Real Estate (ARE) is a REIT that owns and manages campuses for biotech and pharmaceutical companies. Demand for its properties depends on long-term R&D budgets in science. The chart below illustrates the general market trends that can underpin ARE's unique performance.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Alexandria
Shares of Alexandria (ARE), a REIT specializing in biotech real estate, respond to the industry's pulse on a weekly basis. News about venture capital funding for biotech companies, successful clinical trials, and R&D center expansions directly impact demand for their space.
Weekly dynamics of market capitalization of the market segment - Investors specialized
Alexandria's stock, like the entire biotech REIT niche, moves in line with the overall volume of venture capital funding in the sector. Investor appetite for biotech creates a common backdrop for everyone. This chart shows how this niche leader responds to industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Alexandria Real Estate is a REIT specializing in real estate for biotech and pharmaceutical companies. Its success is driven by the growth of the life sciences industry. The chart below shows how this niche focus allows it to perform differently from the real estate market and the broader market.
Market capitalization of the company, segment and market as a whole
ARE - Market capitalization of the company Alexandria
The Alexandria Real Estate Equities (ARE) market cap is a financial valuation of a unique real estate ecosystem for the biotech industry. The chart reflects the value of a portfolio of offices and labs in key innovation clusters such as Boston and San Francisco. Its dynamics are an indicator of the health and investment in the life sciences sector.
ARE - Share of the company's market capitalization Alexandria within the market segment - Investors specialized
Alexandria Real Estate Equities is an investment trust specializing in the development and leasing of office and laboratory space for biotech companies. Its market capitalization is dominant in its niche sector, reflecting its unique expertise and leadership.
Market capitalization of the market segment - Investors specialized
Alexandria Real Estate (ARE) is a unique REIT that owns and manages campuses for biotech and pharmaceutical companies. The chart below shows the market capitalization of specialized investors. Against this backdrop, ARE's focus on science-intensive real estate makes it a key infrastructure partner for the entire industry.
Market capitalization of all companies included in a broad market index - GURU.Markets
Science and technology require specialized infrastructure, and its cost is reflected in the graph. Alexandria Real Estate (ARE) specializes in developing and leasing campuses and laboratories for biotech companies. Its capitalization is a bet on the growth of the innovation economy in leading scientific clusters.
Book value capitalization of the company, segment and market as a whole
ARE - Book value capitalization of the company Alexandria
Alexandria Real Estate's graph maps America's innovation clusters. The company's book value is the aggregate valuation of its unique portfolio of office and laboratory complexes in hubs like Boston and San Francisco. Growth comes from building new buildings for leading biotech companies.
ARE - Share of the company's book capitalization Alexandria within the market segment - Investors specialized
Alexandria Real Estate (ARE) owns unique and strategically important assets. Its sector share consists of clusters of office and laboratory buildings in leading innovation hubs. The chart demonstrates its dominance in providing physical infrastructure for the biotech industry.
Market segment balance sheet capitalization - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and manages campuses for life sciences companies. Their assets include specialized laboratory and office buildings. The book value chart shows the value of this high-tech and sought-after real estate.
Book value of all companies included in the broad market index - GURU.Markets
Alexandria Real Estate owns unique assets—entire campuses and laboratory complexes—that it leases to leading biotech companies. The chart below shows the growth of this real estate portfolio, a physical mecca for life sciences.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Alexandria
Alexandria owns a unique property—science campuses for biotech companies. The market pays a premium for their dominance in this niche and their connection to the most innovative industry. The chart shows how this premium for "science real estate" has changed.
Market to book capitalization ratio in a market segment - Investors specialized
Alexandria Real Estate is an investment fund specializing in biotech real estate. The chart shows the market premium for this unique niche and high-quality tenants, comparing its market capitalization to the value of its specialized laboratory and office complexes.
Market to book capitalization ratio for the market as a whole
Alexandria Real Estate (ARE) is a unique REIT that owns and manages office and laboratory space for biotech companies. Its valuation, unlike the average on this chart, reflects not only the value of the buildings but also its dominance in this niche. The market values its cluster approach and proximity to leading research centers, creating a premium for the assets.
Debts of the company, segment and market as a whole
ARE - Company debts Alexandria
Alexandria Real Estate (ARE) is a unique REIT focused on building campuses for biotech and pharmaceutical companies. This chart shows how the company uses significant debt to finance the construction and acquisition of highly specialized laboratory and office buildings in key innovation hubs like Boston and San Francisco.
Market segment debts - Investors specialized
Alexandria Real Estate (ARE) is a unique REIT that owns and manages campuses for biotech and pharmaceutical companies. This niche sector requires specific expertise and capital investment. This chart illustrates how the company's financial strategy aligns with its status as a leader in its narrow but rapidly growing niche.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Alexandria
Alexandria Real Estate Equities (ARE) is a REIT specializing in office and lab space for biotech companies. This chart shows its financial leverage. Debt is used to build high-tech facilities. A decline in biotech financing could reduce demand for their space and impact the company's ability to service its debt.
Market segment debt to market segment book capitalization - Investors specialized
Alexandria Real Estate (ARE) is a unique REIT that builds and leases offices and labs for biotech companies. Its success is directly linked to the health of the pharmaceutical industry. The chart shows debt trends in the specialty real estate sector, helping to assess the sustainability of Alexandria's niche strategy.
Debt to book value of all companies in the market
Alexandria (ARE) is a REIT building laboratories for biotech companies. The REIT model requires high levels of debt. This chart reflects the average debt load of the entire economy. It clearly demonstrates how the financial structure of ARE and the real estate sector as a whole differs from that of non-financial companies.
P/E of the company, segment and market as a whole
P/E - Alexandria
Alexandria Real Estate Equities (ARE) is a unique investment trust that owns and manages office and laboratory campuses for biotech and pharmaceutical companies. This chart shows how investors value innovation in the life sciences sector. The dynamics depend on the volume of venture capital funding and government grants in biotech.
P/E of the market segment - Investors specialized
Alexandria Real Estate (ARE) is a unique real estate investment trust (REIT) that owns and manages campuses and office space for companies in the life sciences sector (biotech, pharmaceuticals). They create ecosystems for innovation. This chart shows the average valuation for specialized REITs, reflecting how investors value real estate associated with knowledge-intensive industries.
P/E of the market as a whole
Alexandria Real Estate Equities (ARE) is a REIT that owns and develops office and lab space for biotech companies. This chart shows the overall real estate sentiment, but ARE is more interested in the amount of venture capital funding in biotech. The company's valuation is a bet on growth and innovation in the life sciences sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Alexandria
Alexandria Real Estate Equities (ARE) is a unique investment trust that owns and manages campuses for biotech and pharmaceutical companies. This chart reflects investor confidence in the future of the life sciences industry. Its performance is a bet on growing investment in research and development, driving strong demand for ARE's specialized real estate.
Future (projected) P/E of the market segment - Investors specialized
Alexandria Real Estate (ARE) is a REIT specializing in the development and management of high-tech campuses for biotech and pharmaceutical companies. This chart compares the company's future revenue expectations with those for the real estate sector. It reflects investors' confidence in the long-term growth of the life sciences industry.
Future (projected) P/E of the market as a whole
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and manages campuses for biotech and pharmaceutical companies. This graph of overall market expectations for ARE is important for biotech financing. Market optimism makes it easier for startups to raise capital, allowing them to lease lab space from ARE, ensuring strong demand.
Profit of the company, segment and market as a whole
Company profit Alexandria
Alexandria Real Estate Equities (ARE) is a unique REIT that creates and leases campuses for biotech and pharmaceutical companies. The company builds ecosystems where science meets business. This chart shows the financial results of its real estate investment strategy for the innovation economy.
Profit of companies in the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique real estate investor specializing in creating clusters for life science companies. This chart shows the profitability of the specialized real estate sector. For ARE, it's an indicator of the growth and funding of the biotech industry, which requires their high-tech lab and office space.
Overall market profit
Alexandria Real Estate (ARE) is a unique REIT that creates and leases high-tech campuses for biotech and pharmaceutical companies. Its properties are not just offices, but specialized laboratories. Demand is driven by funding in the life sciences sector. This chart provides an overview of the overall market, but the key factor is venture capital in biotech.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Alexandria
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and operates campuses for biotech and pharmaceutical companies in leading innovation clusters across the United States. Its earnings forecast reflects expectations for growing R&D budgets in the life sciences industry. Demand for laboratory space is a key driver for the company.
Future (predicted) profit of companies in the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique investment trust specializing in the development and leasing of campuses for biotech and pharmaceutical companies. The profit outlook for this niche real estate sector depends on funding for R&D in the life sciences. This chart shows analysts' confidence in the continued growth of the biotech industry and its demand for specialized labs.
Future (predicted) profit of the market as a whole
Alexandria Real Estate Equities (ARE) is a REIT specializing in the development and leasing of office and laboratory campuses for biotech companies. Its success is inextricably linked to the health of the life sciences sector. The profit projections shown here influence the amount of venture capital funding available to ARE tenants.
P/S of the company, segment and market as a whole
P/S - Alexandria
Alexandria Real Estate Equities is a unique investment trust that owns office and laboratory campuses for biotech companies. This chart shows the high premium investors pay for its rental income. Its focus on the innovative and rapidly growing life sciences sector ensures high demand for its properties and stable revenue growth.
P/S market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique real estate investment trust (REIT) that owns and manages campuses and office buildings for biotech and pharmaceutical companies. This chart shows the average revenue valuation for the REIT sector, highlighting the premium investors are paying for ARE's niche specialization and proximity to innovation hubs.
P/S of the market as a whole
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and operates office and laboratory campuses for biotech and pharmaceutical companies. The company's business is thriving thanks to growing R&D in the life sciences. This chart provides context for understanding how investors value the niche but rapidly growing biotech real estate sector against the backdrop of the overall economy.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Alexandria
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and manages office and laboratory campuses for biotech and pharmaceutical companies. This chart shows how investors estimate the company's future rental income. It reflects their belief in growth and innovation in the life sciences sector.
Future (projected) P/S of the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and operates campuses and laboratories for biotech and pharmaceutical companies. Its properties are hubs of innovation. This chart illustrates the market premium it commands for its strategic niche, closely tied to the growth and financing of the life sciences sector.
Future (projected) P/S of the market as a whole
Alexandria Real Estate Equities (ARE) is an investment trust specializing in office and lab space for biotech companies. Their success is inextricably linked to the life sciences industry. This market optimism chart is important to ARE. Economic growth and investor risk appetite are driving an influx of funding into biotech, allowing their tenants to expand.
Sales of the company, segment and market as a whole
Company sales Alexandria
Alexandria Real Estate Equities (ARE) is a unique real estate investment trust that owns and manages campuses and office space for life sciences and biotechnology companies. This chart reflects the boom in the biotech industry. The growth in rental revenue is directly related to increased R&D funding in the pharmaceutical and biotech industries, creating strong demand for these properties.
Sales of companies in the market segment - Investors specialized
Alexandria Real Estate (ARE) is a unique REIT that is a leading owner and developer of office and laboratory campuses for biotech and pharmaceutical companies. They create ecosystems for innovation in key clusters across the United States. Their revenue structure reflects stable rental cash flow generated by life sciences giants.
Overall market sales
Alexandria Real Estate Equities (ARE) is a unique investment trust that owns and operates campuses for biotech and pharmaceutical companies in leading innovation clusters across the United States. ARE creates an ecosystem for scientific breakthroughs. This total revenue chart includes the growing life sciences sector, for which Alexandria provides critical infrastructure.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Alexandria
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and operates office and laboratory campuses for life sciences and biotechnology companies. This chart reflects rental income forecasts, which are closely tied to funding levels in the biotech sector and demand for specialized space in clusters like Boston and San Francisco.
Future (projected) sales of companies in the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and manages campuses and office buildings for biotech and pharmaceutical companies. This chart shows forecasts for the niche but rapidly growing life sciences real estate market. It reflects expectations for R&D investment in the biotech sector, which directly drives demand for ARE's labs.
Future (projected) sales of the market as a whole
Alexandria Real Estate Equities (ARE) is an investment fund specializing in real estate for biotech and pharmaceutical companies. This chart, which reflects research investment forecasts, is important for ARE. Increased funding in the life sciences sector directly leads to laboratory and office expansion, driving high demand for the company's specialized properties.
Marginality of the company, segment and market as a whole
Company marginality Alexandria
Alexandria Real Estate Equities (ARE) is an investment trust specializing in office and lab space for biotech companies. This chart demonstrates its high profitability. This profitability is driven by long-term leases in key innovation clusters like Boston and San Francisco, where demand for specialized real estate is very high.
Market segment marginality - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique investment fund specializing in the ownership and management of office and laboratory campuses for biotech and pharmaceutical companies. Profitability is driven by demand from the knowledge-intensive industry. This chart demonstrates the profitability of their niche strategy. A comparison with other REITs highlights their unique competitive advantage.
Market marginality as a whole
Alexandria Real Estate Equities (ARE) is a unique REIT that owns and operates campuses for biotech and pharmaceutical companies. Its success depends on funding and R&D activity in the life sciences sector. This overall profitability chart has little to do with the venture capital and scientific breakthroughs that drive ARE's business.
Employees in the company, segment and market as a whole
Number of employees in the company Alexandria
Alexandria Real Estate Equities (ARE) is a unique REIT that creates and manages campuses for biotech and technology companies in leading innovation clusters. This chart shows a team that doesn't just manage real estate, but builds ecosystems for science and innovation, providing labs and offices for the world's leading researchers.
Share of the company's employees Alexandria within the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique REIT that specializes in creating and managing high-tech campuses for life science companies. This chart demonstrates its dominance in this niche. It reflects the significant share of ARE's expertise in managing laboratory and office space for science in key innovation clusters.
Number of employees in the market segment - Investors specialized
Alexandria Real Estate Equities (ARE) is a unique real estate investor that owns and manages campuses for biotech and pharmaceutical companies. It creates ecosystems for innovation. This chart illustrates how this niche real estate strategy requires specialists to manage complex lab spaces, facilitating scientific breakthroughs.
Number of employees in the market as a whole
Alexandria Real Estate Equities (ARE) is a unique REIT that owns, manages, and develops office and laboratory campuses for biotech and pharmaceutical companies. Its success is directly linked to the growth of the life sciences industry. Overall employment growth, particularly in the R&D sector, which is part of this graph, means that biotech companies are expanding and need more lab space from ARE.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Alexandria (ARE)
Alexandria Real Estate Equities (ARE) is a REIT specializing in life sciences real estate. This chart shows the value of this niche property. The very high market capitalization per employee reflects the fact that the core asset is unique laboratory and office campuses, which require a small team of experts to manage.
Market capitalization per employee (in thousands of dollars) in the market segment - Investors specialized
Alexandria (ARE) is a unique REIT that builds and leases campuses for biotech and technology companies. These aren't just offices, but sophisticated lab spaces. This chart shows the industry average. It helps assess the premium ARE receives over its cost per employee due to its specialization in this high-tech real estate segment.
Market capitalization per employee (in thousands of dollars) for the overall market
Alexandria Real Estate Equities (ARE) is a REIT that specializes in developing and leasing campuses for biotech and pharmaceutical companies. This metric reflects the uniqueness of its niche. Its high cost per employee is a result of owning real estate in key innovation clusters, which drives high demand and rental rates.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Alexandria (ARE)
Alexandria (ARE) is a unique REIT that owns and operates campuses and labs for biotech companies. This is an extremely niche and highly profitable real estate segment. This chart shows how their small staff manages critical R&D infrastructure, allowing them to command high rents and maintain exceptional profitability.
Profit per employee (in thousands of dollars) in the market segment - Investors specialized
Alexandria (ARE) is a REIT (real estate investment trust) that owns "science campuses" (biotech labs). This chart shows the benchmark for "specialized investors." In this "elite" REIT sector, the benchmark is very high. A small staff manages ultra-expensive, "sticky" assets leased to wealthy tenants.
Profit per employee (in thousands of dollars) for the market as a whole
Alexandria Real Estate Equities (ARE) is an investment fund specializing in the development and leasing of office and laboratory campuses for biotech companies. Their employee profitability data demonstrates the uniqueness of their niche. A small team manages a real estate portfolio for the most knowledge-intensive industry, ensuring high asset values and income per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee Alexandria (ARE)
Alexandria Real Estate Equities is an investment fund specializing in the development and leasing of cluster campuses for biotech companies. This chart demonstrates the success of this unique niche strategy. High revenue per employee is the result of providing high-quality, specialized space to leading research centers under long-term contracts.
Sales per employee in the market segment - Investors specialized
Alexandria (ARE) is a unique REIT. They own and manage campuses and labs for biotech and pharmaceutical companies. This is a niche and expensive property. This chart shows how effective their specialized asset management model is. It compares how their team generates rental revenue per employee compared to other office REITs.
Sales per employee for the market as a whole
Alexandria Real Estate (ARE) is a luxury REIT that builds biotech campuses. They own and manage office and lab space in key innovation hubs (Boston, San Francisco). This chart shows the high rental income their team generates by leasing space to the world's most valuable startups.
Short shares by company, segment and market as a whole
Shares shorted by company Alexandria (ARE)
Alexandria (ARE) is a unique REIT that specializes in the construction and management of office and laboratory space for biotech and pharmaceutical companies. This chart shows short bets. The surge in shorts on ARE reflects concerns that the "golden age" of biotech is over, with startups cutting back on R&D and expensive lab space.
Shares shorted by market segment - Investors specialized
Загрузка...
Shares shorted by the overall market
Alexandria (ARE) is a unique REIT that owns high-tech office parks and labs for biotech companies. This chart shows the overall level of fear. When pessimism rises, ARE is betting on science. Investors are watching to see if biotech companies will continue to receive funding and pay rent, or if the capital drought in the sector will lead to empty labs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Alexandria (ARE)
Alexandria (ARE) isn't just a REIT; it owns luxury campuses for biotech giants. Their success is tied to funding R&D in the life sciences sector. The chart shows how overheated investor interest in this niche is (above 70) or, conversely, how much biotech bubble fears are weighing on the stock (below 30).
RSI 14 Market Segment - Investors specialized
Alexandria (ARE) is a unique REIT focused on creating and managing campuses for biotech and pharmaceutical companies. They build cutting-edge labs, not offices. This chart reflects the overall sentiment of investors in the specialized (including scientific) real estate niche. It helps us understand whether the entire biotech REIT sector is overheated amid the rapid growth of the life sciences industry.
RSI 14 for the overall market
Alexandria (ARE) is a unique REIT focused on creating and managing high-tech campuses for biotech and pharmaceutical companies. Their success depends on the flow of venture capital into life sciences. This indicator reflects overall market risk: euphoria (high values) makes it easier for biotech companies to raise capital, which benefits ARE, while panic closes funding windows.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ARE (Alexandria)
Alexandria (ARE) is a unique REIT focused on building and managing campuses for biotech and pharmaceutical companies. This chart shows analyst consensus estimates. Their estimates are based on demand for lab space, the volume of venture capital funding in the life sciences sector, and rental rate dynamics in key clusters.
The difference between the consensus estimate and the actual stock price ARE (Alexandria)
Alexandria (ARE) is a unique REIT focused on owning, managing, and developing biotech and life sciences campuses in key innovation clusters in the United States. This chart shows the gap between the consensus estimate and the price. It reflects whether analysts believe in long-term R&D growth in biotech, and see potential for ARE in this.
Analyst consensus forecast for stock prices by market segment - Investors specialized
Alexandria Real Estate (ARE) is a unique REIT. It's a biotech "landlord," owning campuses and labs that it leases to pharma giants and startups. This chart shows analysts' overall expectations for the specialized REIT sector. It reflects whether experts believe R&D budgets in biotech will grow.
Analysts' consensus forecast for the overall market share price
Alexandria Real Estate (ARE) is a unique REIT that builds and leases high-tech labs and offices for biotech companies. Their business is housing for science. Market expectations, visible in this chart, influence their clients. If investors are pessimistic, biotech companies (ARE's tenants) receive less funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Alexandria
Alexandria (ARE) is a unique REIT that owns neither offices nor warehouses. They build and manage campuses (laboratories and offices) for biotech and pharmaceutical companies in key clusters across the United States. This chart is a barometer of the biotech industry, reflecting the size of R&D budgets and venture capital funding, which drive demand for their specialized real estate.
AKIMA Market Segment Index - Investors specialized
Alexandria (ARE) is a REIT for scientists; the company is the dominant owner of laboratory and office buildings (Life Science) in major US biotech clusters (Boston, San Francisco). This composite metric evaluates the REIT. The chart shows the sector average. This benchmark: how does ARE's unique (biotech) niche differentiate it from the average REIT?
The AKIM Index for the overall market
Alexandria (ARE) is a REIT unique in that it owns and builds campuses (offices and labs) for biotech and pharmaceutical companies in key hubs (Boston, San Francisco). This chart, which reflects the market average, is important for context. It helps assess how ARE, which is dependent on biotech R&D budgets and rates (like a REIT), fits into the overall macroeconomic picture.